Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

748 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1.
Mahdavi M, Prévost K, Balthazar P, Hus IF, Duchesne É, Dumont N, Gagné-Ouellet V, Gagnon C, Laforest-Lapointe I, Massé E. Mahdavi M, et al. Among authors: gagnon c. Comput Struct Biotechnol J. 2024 May 9;23:2097-2108. doi: 10.1016/j.csbj.2024.05.009. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 38803516 Free PMC article.
Correction: Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS).
Hendrickx N, Mentré F, Traschütz A, Gagnon C, Schüle R; ARCA Study Group; EVIDENCE-R. N. D. consortium; Synofzik M, Comets E. Hendrickx N, et al. Among authors: gagnon c. AAPS J. 2024 May 24;26(4):62. doi: 10.1208/s12248-024-00932-8. AAPS J. 2024. PMID: 38789847 No abstract available.
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks.
McDonald EG, Lundby C, Thompson W, Boyd C, Farrell B, Gagnon C, Herbin J, Khuong N, Moriarty F, Pierson T, Scott S, Scott IA, Silvius J, Spinewine A, Steinman MA, Tannenbaum C, Trimble J, Turner JP, Reeve E. McDonald EG, et al. Among authors: gagnon c. Expert Rev Clin Pharmacol. 2024 May-Jun;17(5-6):433-440. doi: 10.1080/17512433.2024.2355270. Epub 2024 May 20. Expert Rev Clin Pharmacol. 2024. PMID: 38739460 Review.
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
Rejnmark L, Gosmanova EO, Khan AA, Makita N, Imanishi Y, Takeuchi Y, Sprague S, Shoback DM, Kohlmeier L, Rubin MR, Palermo A, Schwarz P, Gagnon C, Tsourdi E, Zhao C, Makara MA, Ominsky MS, Lai B, Ukena J, Sibley CT, Shu AD. Rejnmark L, et al. Among authors: gagnon c. Adv Ther. 2024 Jun;41(6):2500-2518. doi: 10.1007/s12325-024-02843-8. Epub 2024 Apr 30. Adv Ther. 2024. PMID: 38691316 Clinical Trial.
Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS).
Hendrickx N, Mentré F, Traschütz A, Gagnon C, Schüle R; ARCA Study Group; EVIDENCE-R. N. D. consortium; Synofzik M, Comets E. Hendrickx N, et al. Among authors: gagnon c. AAPS J. 2024 Apr 30;26(3):57. doi: 10.1208/s12248-024-00925-7. AAPS J. 2024. PMID: 38689016
748 results